Jamal Rana: The LDL Cholesterol Goal Post Has Moved
Jamal Rana, Professor in the Department of Clinical Science at Kaiser Permanente Bernard J. Tyson School of Medicine, shared on LinkedIn:
”Goal post to treat LDL cholesterol has moved in patients with high risk for heart disease. Was thrilled to be part of The Wall Street Journal coverage of the biggest trials presented at AHA Scientific Sessions. We are now in era where multiple options exist to aggressively treat LDL cholesterol in high risk patients to prevent heart disease.
A PCSK9 inhibitor, evolocumab or Repatha, used on top of lipid-lowering therapy, including a high-intensity statin, significantly cuts the risk of major adverse cardiovascular events compared with placebo when used in patients without a prior history of myocardial infarction or stroke, the VESALIUS-CV study shows over a median follow-up of 4.6 years.
A single injection of a gene-edited protein was deemed productive and safe in patients with dyslipidemia that was unresponsive to lipid-lowering therapy, according to a phase I trial. IV CTX310 is an in vivo CRISPR-Cas9 gene-editing drug product targeting ANGPTL3.
CORALreef Lipids trial demonstrated that treatment with enlicitide decanoate, once-daily oral PCSK9-inhibitor, resulted in a statistically significant and clinically meaningful reduction in LDL cholestrol.”
Check here for more information.
Stay updated on all scientific advances with Hemostasis Today.
-
May 25, 2026, 16:27Gashaw Arega: Advancing Bleeding Disorders Care in Africa
-
May 25, 2026, 16:20Ai Phi Thuy Ho: Varicose Veins Show How Blood Flow Inside the Body Affects What You See on the Skin
-
May 25, 2026, 16:11Ashraf Ali Alsmadi: Recognizing the Difference Between Air Embolism and Pulmonary Embolism
-
May 25, 2026, 16:07Jeanett Mphume: Lymphedema and the Importance of Early Diagnosis
-
May 25, 2026, 15:53Nicolas Nesseler: Do We Overlook Factor XIII Deficiency in VA-ECMO Patients?
-
May 25, 2026, 15:47Wadha Al-Muftah: WHO Adopts Landmark Resolution on Precision Medicine
-
May 25, 2026, 15:43Robert Brown: Evidence-Based Management of Obstetric Hemorrhage
-
May 25, 2026, 15:31Tagreed Alkaltham: Beyond the Blood Bank – How Strong Systems Save Lives Before Emergencies Begin
-
May 25, 2026, 15:28Julie Makani: African Health Science Partnerships at INTEREST 2026